The risk of AIDS-defining events is decreasing over time in the German HIV-1 Seroconverter Cohort
<p>Abstract</p> <p>Background</p> <p>With ageing of the HIV-infected population, long-term exposure to treatment, varying adherence, emerging resistance and complications to therapies, effectiveness of Highly Active Antiretroviral Therapy (HAART) needs to be monitored c...
Main Authors: | Altmann Mathias, an der Heiden Matthias, Scheufele Ramona, Hartmann Katrin, Houareau Claudia, Bartmeyer Barbara, Hamouda Osamah |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-04-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2334/12/94 |
Similar Items
-
Treatment of Chronic Hepatitis B with Tenofovir
by: Mohsen Akhondi Meybodi, et al.
Published: (2018-07-01) -
First line treatment response in patients with transmitted HIV drug resistance and well defined time point of HIV infection: updated results from the German HIV-1 seroconverter study.
by: Fabia Zu Knyphausen, et al.
Published: (2014-01-01) -
Terapia hipolipemiante em situações especiais: síndrome de imunodeficiência adquirida Hypolipidemic therapy under special conditions: acquired immune deficiency syndrome
by: Pai Ching Yu, et al.
Published: (2005-10-01) -
Incidence of Hepatotoxicity and Factors Associated During Highly Active Antiretroviral Therapy in People Living with HIV in Ethiopia: A Prospective Cohort Study
by: Gebremicael G, et al.
Published: (2021-03-01) -
CCR5Delta32 genotypes in a German HIV-1 seroconverter cohort and report of HIV-1 infection in a CCR5Delta32 homozygous individual.
by: Djin-Ye Oh, et al.
Published: (2008-01-01)